GI-5005 THERAPEUTIC VACCINE PLUS PEG-IFN/RIBAVIRIN IMPROVES SUSTAINED VIROLOGIC RESPONSE VERSUS PEG-IFN/RIBAVIRIN IN PRIOR NON-RESPONDERS WITH GENOTYPE 1 CHRONIC HCV INFECTION

被引：0
|
作者：
Pockros, Paul [1 ]
Jacobson, Ira [2 ]
Boyer, Thomas D. [3 ]
Schiff, Eugene R. [4 ]
Everson, Gregory T. [5 ]
Lee, William M. [6 ]
Vierling, John M. [7 ,8 ]
Lawitz, Eric [9 ]
Kugelmas, Marcelo [10 ,11 ]
Tsai, Naoky [12 ]
Shiffman, Mitchell L. [13 ]
Brown, Robert S. [14 ]
Armstrong, Brian R. [15 ]
Mattson, Alicia [16 ]
Rodell, Timothy C. [16 ]
Apelian, David [16 ]
机构：
[1] Scripps Clin, La Jolla, CA 92037 USA
[2] Weill Cornell Med Coll, Ctr Study Hepatitis C, New York, NY USA
[3] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA
[4] Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA
[5] Univ Colorado Denver, Dept Med, Aurora, CO USA
[6] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[7] Baylor Coll Med, Dept Med & Surg, Houston, TX 77030 USA
[8] St Lukes Episcopal Hosp, Houston, TX 77030 USA
[9] Alamo Med Res, San Antonio, TX USA
[10] PC, S Denver Gastroenterol, Englewood, CO USA
[11] Swedish Med Ctr, Ctr Dis Liver & Pancreas, Englewood, CO 80110 USA
[12] Univ Hawaii, Honolulu, HI 96822 USA
[13] Liver Inst Virginia, Newport News, VA USA
[14] Columbia Univ, Coll Phys & Surg, New York, NY USA
[15] QST Consultat, Allendale, MI USA
[16] Globelmmune, Louisville, CO USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LB-6
引用
收藏
页码：404A / 405A
页数：2
相关论文
共 50 条
  • [31] EVALUATION OF PREDICTIVE FACTORS ASSOCIATED WITH SUSTAINED VIRAL RESPONSE TO PEG-IFN PLUS RIBAVIRIN COMBINATION THERAPY IN JAPANESE CHRONIC HEPATITIS C PATIENTS
    Hashimoto, Hiroaki
    Itoh, Yoshito
    Minami, Masahito
    Yasui, Kohichiroh
    Mitsuyoshi, Hironori
    Yamaguchi, Kanji
    Iwai, Masaki
    Okanoue, Takeshi
    Yoshikawa, Toshikazu
    HEPATOLOGY, 2008, 48 (04) : 863A - 863A
  • [32] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN alpha) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1
    Antonov, Krasimir
    Jelev, Deian
    Ivanova, A.
    Krastev, Zahariy
    JOURNAL OF IMAB, 2011, 17 (01): : 197 - 199
  • [33] BETTER SUSTAINED CONTROL OF CHRONIC GENOTYPE 1 HCV INFECTIONS WITH PEG-IFN ALFA-2A THAN WITH PEG-IFN ALFA-2B TREATMENT: RESULTS OF DAILY CLINICAL PRACTICE
    Orlandini, A.
    Borghi, V.
    Sacchelli, L.
    Valli, A.
    Bertoni, R.
    Verucchi, G.
    Piergentili, B.
    Testa, L.
    Andreone, P.
    Massari, M.
    Carradori, S. D.
    Ghinelli, F.
    Sacchini, D.
    Abbati, G.
    Pietrangelo, A.
    Vandelli, C.
    Ferrari, C.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S2 - S3
  • [34] Role of BAFF in Prediction of Rapid Virological Response to PEG-IFN α-2a plus Ribavirin in Patients with Chronic Hepatitis C
    Liu, Jing
    Xu, Zhen
    Xu, Wen-Xiong
    Mo, Zhi-Shuo
    Zhu, Xiang
    Gao, Zhi-Liang
    HEPATOLOGY, 2013, 58 : 443A - 443A
  • [35] PEG-IFN and ribavirin re-treatment of HCV-1b cirrhosis non responder to conventional combination therapy
    Morisco, F.
    Amoruso, D.
    Stroffolini, T.
    Caporaso, N.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 (05) : 391 - 392
  • [36] Maintenance of a Th1 cytokine response induced by Peg-IFN plus ribavirin controls viral replication in genotype 1 patients with chronic hepatitis C (CHC)
    Trapero, M
    Viton, M
    Moreno-Monteagudo, JA
    Muñoz, C
    Borque, MJ
    Quintana, NE
    Garcia-Buey, L
    Moreno-Otero, R
    HEPATOLOGY, 2004, 40 (04) : 325A - 325A
  • [37] BASELINE PLATELET COUNT PREDICTS SUSTAINED VIRAL RESPONSE (SVR) IN THE TREATMENT OF CHRONIC HEPATITIS C WITH PEG-IFN α-2B AND RIBAVIRIN: RESULTS FROM THE GERMAN PEG-IFN α-2B OBSERVATIONAL STUDY
    Mauss, Stefan
    Zehnter, Elmar
    Manns, Michael P.
    Teuber, Gerlinde
    Dahhan, Tarek
    Kaiser, Stephan
    Meyer, Ulrike
    Witthoeft, Thomas
    Moeller, Bernd
    Dikopoulos, Nektarios
    Brack, Jochen
    Bilzer, Manfred
    Tossing, Gudrun
    Hueppe, Dietrich
    HEPATOLOGY, 2009, 50 (04) : 1032A - 1032A
  • [38] Cost effective prediction of sustained response to IFN α-213 or PEG-IFN α-2B plus ribavirin computing infected cells dynamics by early ALT and HCV-RNA decline
    Colombatto, P
    Ciccorossi, P
    Oliveri, F
    Maina, AM
    Civitano, L
    Coco, B
    Flichman, D
    Sacco, R
    Bonino, F
    Brunetto, M
    JOURNAL OF HEPATOLOGY, 2005, 42 : 203 - 203
  • [39] Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin
    Fujino, Tatsuya
    Nakamuta, Makoto
    Aoyagi, Yoko
    Kohjima, Motoyuki
    Satoh, Takeaki
    Fukuda, Mika
    Ishibashi, Hiromi
    Yatsuhashi, Hiroshi
    Enjoji, Munechika
    MEDICAL SCIENCE MONITOR, 2011, 17 (12): : CR687 - CR691
  • [40] PROTEIN PATHWAY BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR)TO PEGYLATED INTERFERON (PEG-IFN) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C)
    Younossi, Z.
    Limongi, D.
    Stepanova, M.
    Pierobon, M.
    Afendy, A.
    Liotta, L.
    Petricoin, E.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S420 - S420
12345